DE69501944T2 - Arzneimittel zur Vorbeugung oder Behandlung von chronischem Rheumatismus und Sepsis - Google Patents
Arzneimittel zur Vorbeugung oder Behandlung von chronischem Rheumatismus und SepsisInfo
- Publication number
- DE69501944T2 DE69501944T2 DE69501944T DE69501944T DE69501944T2 DE 69501944 T2 DE69501944 T2 DE 69501944T2 DE 69501944 T DE69501944 T DE 69501944T DE 69501944 T DE69501944 T DE 69501944T DE 69501944 T2 DE69501944 T2 DE 69501944T2
- Authority
- DE
- Germany
- Prior art keywords
- sepsis
- medicines
- prevent
- treat chronic
- chronic rheumatism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32207394 | 1994-12-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69501944D1 DE69501944D1 (de) | 1998-05-07 |
DE69501944T2 true DE69501944T2 (de) | 1998-07-30 |
Family
ID=18139621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69501944T Expired - Fee Related DE69501944T2 (de) | 1994-12-26 | 1995-12-22 | Arzneimittel zur Vorbeugung oder Behandlung von chronischem Rheumatismus und Sepsis |
Country Status (5)
Country | Link |
---|---|
US (1) | US5753691A (de) |
EP (1) | EP0720849B1 (de) |
KR (1) | KR960021021A (de) |
CA (1) | CA2165919A1 (de) |
DE (1) | DE69501944T2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0818439B1 (de) * | 1996-07-02 | 1999-10-13 | Nisshin Flour Milling Co., Ltd. | Imid derivate |
EP2152308A1 (de) | 2007-05-29 | 2010-02-17 | Novartis Ag | Neue anzeigen für eine anti-il-i-beta-therapie |
EP4023301A3 (de) * | 2020-12-29 | 2022-09-07 | Huscion Co., Ltd. | Piperlonguminbasierte verbindung und immunregulator damit |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61229801A (ja) * | 1985-04-03 | 1986-10-14 | Taki Chem Co Ltd | 植物生長調節剤 |
JPS61230798A (ja) * | 1985-04-03 | 1986-10-15 | Taki Chem Co Ltd | メタン醗酵促進剤 |
JPH0720930B2 (ja) * | 1988-07-09 | 1995-03-08 | 明治製菓株式会社 | ピロリジノン化合物及び脳機能障害改善剤 |
JP2680664B2 (ja) * | 1989-02-28 | 1997-11-19 | 日清製粉株式会社 | ピロリジノン誘導体 |
IT1231921B (it) * | 1989-06-12 | 1992-01-15 | Sigma Tau Ind Farmaceuti | 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
-
1995
- 1995-12-21 CA CA002165919A patent/CA2165919A1/en not_active Abandoned
- 1995-12-22 EP EP95120407A patent/EP0720849B1/de not_active Expired - Lifetime
- 1995-12-22 US US08/577,338 patent/US5753691A/en not_active Expired - Fee Related
- 1995-12-22 DE DE69501944T patent/DE69501944T2/de not_active Expired - Fee Related
- 1995-12-26 KR KR1019950056109A patent/KR960021021A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0720849A2 (de) | 1996-07-10 |
KR960021021A (ko) | 1996-07-18 |
CA2165919A1 (en) | 1996-06-27 |
DE69501944D1 (de) | 1998-05-07 |
EP0720849A3 (de) | 1996-07-17 |
EP0720849B1 (de) | 1998-04-01 |
US5753691A (en) | 1998-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI950587A (fi) | Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä | |
DE69432299T2 (de) | Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen | |
DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
DE69117117D1 (de) | Reinigungszusammensetzung zur Vorbeugung und Milderung von Hautreizungen | |
DE4497012T1 (de) | Verbesserungen bezüglich der katalytischen Behandlung von Maschinenabgas | |
DE59601624D1 (de) | Verwendung von 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen zur prophylaxe und behandlung der folgen der akuten und chronischen zerebralen minderdurchblutung sowie neurodegenerativer erkrankungen | |
FI972433A0 (fi) | Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia | |
DE69501493D1 (de) | Entfernung von Feuchtigkeit und Passivierung von Oberflächen | |
DE69434223D1 (de) | In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper | |
NO971900D0 (no) | Blandinger og behandling av multippel sklerose | |
DE69302439D1 (de) | Topisches Präparat zur Verhütung oder Behandlung der Akne Vulgaris | |
DE69825319D1 (de) | Präparat zur vorbeugung und behandlung von entzündungen | |
NO952820D0 (no) | Behandling av avfallspetroleum | |
DE69221617D1 (de) | Aufbereitung von flüssigkeit | |
ATA66594A (de) | Mittel zur ad- und absorption von fluiden | |
DE69303930D1 (de) | Behandlung von mit quecksilber verunreinigtem schlamm | |
DE69306335D1 (de) | Prevention und Behandlung von Atherosclerosis | |
DE69314590T2 (de) | Behandlung von Proteinhaltigen Körperflüssigkeiten | |
DE69501944T2 (de) | Arzneimittel zur Vorbeugung oder Behandlung von chronischem Rheumatismus und Sepsis | |
DE69306831D1 (de) | Behandlung von Flüssigkeiten | |
DE69306260D1 (de) | Behandlung von abwasser | |
ATE224711T1 (de) | Formulierung zur behandlung und/oder vorbeugung von dementia | |
ATE288279T1 (de) | Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor | |
DE69318644D1 (de) | Behandlung von Flüssigkeiten | |
FI945200A (fi) | Jäteveden puhdistus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: NISSHIN SEIFUN GROUP INC., TOKIO/TOKYO, JP |
|
8339 | Ceased/non-payment of the annual fee |